Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102757232 | 10275723 | 2 | F | 20140522 | 20151228 | 20140703 | 20151231 | EXP | JP-JNJFOC-20140617099 | JANSSEN | 25.00 | YR | A | F | Y | 0.00000 | 20151231 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102757232 | 10275723 | 1 | SS | XEPLION | PALIPERIDONE PALMITATE | 1 | Intramuscular | N | DHB4K02 | 0 | 75 | MG | INJECTION | ||||||
| 102757232 | 10275723 | 2 | SS | XEPLION | PALIPERIDONE PALMITATE | 1 | Intramuscular | N | DHB4K02 | 0 | 75 | MG | INJECTION | ||||||
| 102757232 | 10275723 | 3 | SS | XEPLION | PALIPERIDONE PALMITATE | 1 | Intramuscular | N | DHB4K02 | 0 | 75 | MG | INJECTION | ||||||
| 102757232 | 10275723 | 4 | SS | XEPLION | PALIPERIDONE PALMITATE | 1 | Intramuscular | N | DHB4K02 | 0 | 75 | MG | INJECTION | ||||||
| 102757232 | 10275723 | 5 | PS | XEPLION | PALIPERIDONE PALMITATE | 1 | Intramuscular | N | DHB4K02 | 22264 | 75 | MG | INJECTION | ||||||
| 102757232 | 10275723 | 6 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | N | 20272 | 2 | MG | UNSPECIFIED | QD | ||||||
| 102757232 | 10275723 | 7 | C | TRIAZOLAM. | TRIAZOLAM | 1 | Oral | 0 | .25 | MG | UNSPECIFIED | QD | |||||||
| 102757232 | 10275723 | 8 | C | ARTANE | TRIHEXYPHENIDYL HYDROCHLORIDE | 1 | Oral | 0 | 8 | MG | UNSPECIFIED | QD | |||||||
| 102757232 | 10275723 | 9 | C | RIVOTRIL | CLONAZEPAM | 1 | Oral | 0 | 1 | MG | UNSPECIFIED | QD | |||||||
| 102757232 | 10275723 | 10 | C | BOFUTSUSHOSAN | HERBALS | 1 | Oral | 0 | 22.5 | MG | UNSPECIFIED | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102757232 | 10275723 | 1 | Schizophrenia |
| 102757232 | 10275723 | 2 | Schizophrenia |
| 102757232 | 10275723 | 3 | Schizophrenia |
| 102757232 | 10275723 | 4 | Schizophrenia |
| 102757232 | 10275723 | 5 | Schizophrenia |
| 102757232 | 10275723 | 6 | Schizophrenia |
| 102757232 | 10275723 | 7 | Insomnia |
| 102757232 | 10275723 | 8 | Extrapyramidal disorder |
| 102757232 | 10275723 | 9 | Mood altered |
| 102757232 | 10275723 | 10 | Constipation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102757232 | 10275723 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102757232 | 10275723 | Myocardial infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102757232 | 10275723 | 1 | 20131205 | 20131205 | 0 | |
| 102757232 | 10275723 | 2 | 20140106 | 20140106 | 0 | |
| 102757232 | 10275723 | 3 | 20140203 | 20140203 | 0 | |
| 102757232 | 10275723 | 4 | 20140331 | 20140331 | 0 | |
| 102757232 | 10275723 | 5 | 20140303 | 20140303 | 0 | |
| 102757232 | 10275723 | 6 | 200902 | 20140512 | 0 |